LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications from the field of Pharma & Biopharma focused on GPC/SEC | LabRulez LCMS

    Size Exclusion Chromatography Analysis of a Monoclonal Antibody and Antibody Drug Conjugate

    Applications
    | 2019 | Agilent Technologies
    GPC/SEC
    Instrumentation
    GPC/SEC
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Simultaneous Determination of Molecular Size, Concentration, and Impurity Composition of Biotherapeutics with SEC and the Biopharmaceutical Platform Solution with UNIFI

    Applications
    | 2014 | Waters
    GPC/SEC
    Instrumentation
    GPC/SEC
    Manufacturer
    Waters
    Industries
    Pharma & Biopharma

    Evaluating the Performance of the ACQUITY Arc Bio UHPLC System for the Size-Exclusion Chromatography Analysis of a Monoclonal Antibody

    Applications
    | 2018 | Waters
    GPC/SEC
    Instrumentation
    GPC/SEC
    Manufacturer
    Waters
    Industries
    Pharma & Biopharma

    SEC Coupled to High-Resolution Mass Spectrometry for Detailed Characterization of mAbs and ADCs

    Applications
    | 2018 | Agilent Technologies
    LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, GPC/SEC
    Instrumentation
    LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, GPC/SEC
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Agilent BioHPLC Columns - Characterization of NIST Monoclonal Antibody Critical Quality Attributes - Application Compendium

    Guides
    | 2019 | Agilent Technologies
    Consumables, HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC columns, GPC/SEC, LC/SQ
    Instrumentation
    Consumables, HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC columns, GPC/SEC, LC/SQ
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma, Proteomics , Clinical Research

    A COMBINED WORKFLOW FOR IN-DEPTH CHARACTERIZATION OF CYSTEINE-CONJUGATED ANTIBODY DRUG CONJUGATES

    Posters
    | 2015 | Waters
    HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, 2D-LC, GPC/SEC
    Instrumentation
    HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, 2D-LC, GPC/SEC
    Manufacturer
    Waters
    Industries
    Pharma & Biopharma

    High-throughput and Sensitive Size Exclusion Chromatography (SEC) of Biologics Using Agilent AdvanceBio SEC Columns

    Applications
    | 2017 | Agilent Technologies
    Consumables, LC columns, GPC/SEC
    Instrumentation
    Consumables, LC columns, GPC/SEC
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    A Comprehensive Workflow to Optimize and Execute Protein Aggregate Studies

    Applications
    | 2017 | Agilent Technologies
    GPC/SEC
    Instrumentation
    GPC/SEC
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Size Exclusion Chromatography/ Mass Spectrometry Analysis of Antibody Drug Conjugates Using the Agilent 1260 Infinity II Bio-Inert LC

    Applications
    | 2016 | Agilent Technologies
    LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, GPC/SEC
    Instrumentation
    LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, GPC/SEC
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Impact of LC System Dispersion on the Size-Exclusion Chromatography Analysis of Monoclonal IgG Antibody Aggregates and Fragments: Selecting the Optimal Column for Your Method

    Applications
    | 2019 | Waters
    GPC/SEC
    Instrumentation
    GPC/SEC
    Manufacturer
    Waters
    Industries
    Pharma & Biopharma
     

    Related content


    Introducing the Mnova Purification Suite: your solution for streamlined chromatography purifications!

    Mo, 8.4.2024
    Mestrelab Research

    TRIO OF UTA CHEMISTS RECOGNIZED AS LEADING LIGHTS

    Th, 2.5.2024
    The University of Texas at Arlington

    “Fat can be extracted even from thousand-year-old pottery,” says V. Brychová

    We, 1.5.2024
    Akademie věd České republiky
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike